Associations of variants of CNR1 with obesity and obesity-related traits in Chinese women

Gene

Volumn 495, Issue 2, 2012, Pages 194-198

  Zhuang, Maoqiang ^a,e   Yang, Yajun ^b,c   Cao, Feifei ^a   Lu, Ming ^a,b   Wang, Xiaofeng ^b,c   Zhang, Juan ^c   Chen, Xingdong ^b   Cheng, Ping ^a,e   Zhang, Nana ^a,e   Ye, Weimin ^b,d   Jin, Li ^b,c  

^a SHANDONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c CMC Institute of Health Sciences   (China)

^d KAROLINSKA INSTITUTE   (Sweden)

^e SHANDONG UNIVERSITY   (China)

Author keywords

China; CNR1; Obesity; Overweight; Polymorphism; Women

Indexed keywords

ALANINE AMINOTRANSFERASE; ENDOCANNABINOID; ENDOCANNABINOID RECEPTOR 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CHINESE; COHORT ANALYSIS; FEMALE; GENETIC ASSOCIATION; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST HIP RATIO;

ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MIDDLE AGED; OBESITY; OVERWEIGHT; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, CANNABINOID, CB1; TRIGLYCERIDES; WAIST-HIP RATIO;

EID: 84862804785     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.12.037     Document Type: Article

References (30)

1. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
2. Basen-Engquist K., Chang M. Obesity and cancer risk: recent review and evidence. Curr. Oncol. Rep. 2011, 13:71-76.
3. Benzinou M., et al. Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations. Hum. Mol. Genet. 2008, 17:1916-1921.
4. Chrostowska M., Szyndler A., Paczwa P., Narkiewicz K. Impact of abdominal obesity on the frequency of hypertension and cardiovascular disease in Poland-results from the IDEA study (International Day for the Evaluation of Abdominal Obesity). Blood Press. 2010, 20:145-152.
5. Colleran K., Pai H. Rimonabant: a novel approach for the treatment of obesity and cardiometabolic risk by blockade of the endocannabinoid system. Future Cardiol. 2007, 3:497-505.
6. De Luis D.A., et al. Roles of G1359A polymorphism of the cannabinoid receptor gene (CNR1) on weight loss and adipocytokines after a hypocaloric diet. Nutr. Hosp. 2011, 26:317-322.
7. Di Marzo V., Bifulco M., De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nat. Rev. Drug Discov. 2004, 3:771-784.
8. Dinu I.R., Popa S., Bicu M., Mota E., Mota M. The implication of CNR1 gene's polymorphisms in the modulation of endocannabinoid system effects. Rom. J. Intern. Med. 2009, 47:9-18.
9. Feng Q., et al. A common CNR1 (cannabinoid receptor 1) haplotype attenuates the decrease in HDL cholesterol that typically accompanies weight gain. PLoS One 2010, 5:e15779.
10. Frost M., et al. Polymorphisms in the endocannabinoid receptor 1 in relation to fat mass distribution. Eur. J. Endocrinol. 2010, 163:407-412.
11. Jaeger J.P., Mattevi V.S., Callegari-Jacques S.M., Hutz M.H. Cannabinoid type-1 receptor gene polymorphisms are associated with central obesity in a Southern Brazilian population. Dis. Markers 2008, 25:67-74.
12. Laczmanski L., Milewicz A., Dunajska K., Jedrzejczuk D., Pawlak M., Lwow F. Endocannabinoid type 1 receptor gene (CNR1) polymorphisms (rs806381, rs10485170, rs6454674, rs2023239) and cardiovascular risk factors in postmenopausal women. Gynecol. Endocrinol. 2011, 27:1023-1027.
13. Lakoski S.G., et al. The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). J. Hum. Hypertens. 2010, 25:73-79.
14. Lazzari P., Sanna A., Mastinu A., Cabasino S., Manca I., Pani L. Weight loss induced by rimonabant is associated with an altered leptin expression and hypothalamic leptin signaling in diet-induced obese mice. Behav. Brain Res. 2010, 217:432-438.
15. Leite C.E., Mocelin C.A., Petersen G.O., Leal M.B., Thiesen F.V. Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity. Pharmacol. Rep. 2009, 61:217-224.
16. Lieb W., et al. Variants in the CNR1 and the FAAH genes and adiposity traits in the community. Obesity (Silver Spring) 2009, 17:755-760.
17. Liu Y.Z., et al. Powerful bivariate genome-wide association analyses suggest the SOX6 gene influencing both obesity and osteoporosis phenotypes in males. PLoS One 2009, 4:e6827.
18. Ma L., et al. Evaluation of A2BP1 as an obesity gene. Diabetes 2010, 59:2837-2845.
19. Milewicz A., et al. Are endocannabinoid type 1 receptor gene (CNR1) polymorphisms associated with obesity and metabolic syndrome in postmenopausal Polish women?. Int. J. Obes. (Lond) 2010, 35:373-377.
20. Muller T.D., et al. No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents. Mol. Genet. Metab. 2007, 90:429-434.
21. Ng M.C., et al. Genome-wide association of BMI in African Americans. Obesity (Silver Spring) 2011, 10.1038/oby.2011.154.
22. Peeters A., Beckers S., Mertens I., Van Hul W., Van Gaal L. The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men. Endocrine 2007, 31:138-141.
23. Quarta C., et al. CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. Cell Metab. 2010, 11:273-285.
24. Ravinet Trillou C., Delgorge C., Menet C., Arnone M., Soubrie P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int. J. Obes. Relat. Metab. Disord. 2004, 28:640-648.
25. Russo P., et al. Genetic variations at the endocannabinoid type 1 receptor gene (CNR1) are associated with obesity phenotypes in men. J. Clin. Endocrinol. Metab. 2007, 92:2382-2386.
26. Shi X.D., et al. Prevalence of obesity and associated risk factors in Northeastern China. Diabetes Res. Clin. Pract. 2010, 91:389-394.
27. Wang X., et al. Rationales, design and recruitment of the Taizhou Longitudinal Study. BMC Publ. Health 2009, 9:223.
28. Wang K., et al. A genome-wide association study on obesity and obesity-related traits. PLoS One 2011, 6:e18939.
29. Zhang P.W., et al. Human cannabinoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol. Psychiatry 2004, 9:916-931.
30. Zhou B.F. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed. Environ. Sci. 2002, 15:83-96.